Cargando…

Endogenous hyperinsulinism: diagnostic and therapeutic difficulties

Endogenous hyperinsulinism is an abnormal clinical condition that involves excessive insulin secretion, related in 55% of cases to insulinoma. Other causes are possible such as islet cell hyperplasia, nesidioblastosis or antibodies to insulin or to the insulin receptor. Differentiation between these...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouta, Esma Leila, Jerraya, Hichem, Dougaz, Wejih, Chaouech, Mohamed Ali, Bouasker, Ibtissem, Nouira, Ramzi, Dziri, Chadly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689824/
https://www.ncbi.nlm.nih.gov/pubmed/31448019
http://dx.doi.org/10.11604/pamj.2019.33.57.18885
_version_ 1783443093274492928
author Gouta, Esma Leila
Jerraya, Hichem
Dougaz, Wejih
Chaouech, Mohamed Ali
Bouasker, Ibtissem
Nouira, Ramzi
Dziri, Chadly
author_facet Gouta, Esma Leila
Jerraya, Hichem
Dougaz, Wejih
Chaouech, Mohamed Ali
Bouasker, Ibtissem
Nouira, Ramzi
Dziri, Chadly
author_sort Gouta, Esma Leila
collection PubMed
description Endogenous hyperinsulinism is an abnormal clinical condition that involves excessive insulin secretion, related in 55% of cases to insulinoma. Other causes are possible such as islet cell hyperplasia, nesidioblastosis or antibodies to insulin or to the insulin receptor. Differentiation between these diseases may be difficult despite the use of several morphological examinations. We report six patients operated on for endogenous hyperinsulinism from 1(st) January 2000 to 31(st) December 2015. Endogenous hyperinsulinism was caused by insulinoma in three cases, endocrine cells hyperplasia in two cases and no pathological lesions were found in the last case. All patients typically presented with adrenergic and neuroglycopenic symptoms with a low blood glucose level concomitant with high insulin and C-peptide levels. Computed tomography showed insulinoma in one case out of two. MRI was carried out four times and succeeded to locate the lesion in the two cases of insulinoma. Endoscopic ultrasound showed one insulinoma and provided false positive findings three times out of four. Intra operative ultrasound succeeded to localize the insulinoma in two cases but was false positive in two cases. Procedures were one duodenopancreatectomy, two left splenopancreatectomy and two enucleations. For the sixth case, no lesion was radiologically objectified. Hence, a left blind pancreatectomy was practised but the pathological examination showed normal pancreatic tissue. Our work showed that even if morphological examinations are suggestive of insulinoma, other causes of endogenous hyperinsulinism must be considered and therefore invasive explorations should be carried out.
format Online
Article
Text
id pubmed-6689824
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-66898242019-08-23 Endogenous hyperinsulinism: diagnostic and therapeutic difficulties Gouta, Esma Leila Jerraya, Hichem Dougaz, Wejih Chaouech, Mohamed Ali Bouasker, Ibtissem Nouira, Ramzi Dziri, Chadly Pan Afr Med J Case Series Endogenous hyperinsulinism is an abnormal clinical condition that involves excessive insulin secretion, related in 55% of cases to insulinoma. Other causes are possible such as islet cell hyperplasia, nesidioblastosis or antibodies to insulin or to the insulin receptor. Differentiation between these diseases may be difficult despite the use of several morphological examinations. We report six patients operated on for endogenous hyperinsulinism from 1(st) January 2000 to 31(st) December 2015. Endogenous hyperinsulinism was caused by insulinoma in three cases, endocrine cells hyperplasia in two cases and no pathological lesions were found in the last case. All patients typically presented with adrenergic and neuroglycopenic symptoms with a low blood glucose level concomitant with high insulin and C-peptide levels. Computed tomography showed insulinoma in one case out of two. MRI was carried out four times and succeeded to locate the lesion in the two cases of insulinoma. Endoscopic ultrasound showed one insulinoma and provided false positive findings three times out of four. Intra operative ultrasound succeeded to localize the insulinoma in two cases but was false positive in two cases. Procedures were one duodenopancreatectomy, two left splenopancreatectomy and two enucleations. For the sixth case, no lesion was radiologically objectified. Hence, a left blind pancreatectomy was practised but the pathological examination showed normal pancreatic tissue. Our work showed that even if morphological examinations are suggestive of insulinoma, other causes of endogenous hyperinsulinism must be considered and therefore invasive explorations should be carried out. The African Field Epidemiology Network 2019-05-27 /pmc/articles/PMC6689824/ /pubmed/31448019 http://dx.doi.org/10.11604/pamj.2019.33.57.18885 Text en © Esma Leila Gouta et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Series
Gouta, Esma Leila
Jerraya, Hichem
Dougaz, Wejih
Chaouech, Mohamed Ali
Bouasker, Ibtissem
Nouira, Ramzi
Dziri, Chadly
Endogenous hyperinsulinism: diagnostic and therapeutic difficulties
title Endogenous hyperinsulinism: diagnostic and therapeutic difficulties
title_full Endogenous hyperinsulinism: diagnostic and therapeutic difficulties
title_fullStr Endogenous hyperinsulinism: diagnostic and therapeutic difficulties
title_full_unstemmed Endogenous hyperinsulinism: diagnostic and therapeutic difficulties
title_short Endogenous hyperinsulinism: diagnostic and therapeutic difficulties
title_sort endogenous hyperinsulinism: diagnostic and therapeutic difficulties
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689824/
https://www.ncbi.nlm.nih.gov/pubmed/31448019
http://dx.doi.org/10.11604/pamj.2019.33.57.18885
work_keys_str_mv AT goutaesmaleila endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties
AT jerrayahichem endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties
AT dougazwejih endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties
AT chaouechmohamedali endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties
AT bouaskeribtissem endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties
AT nouiraramzi endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties
AT dzirichadly endogenoushyperinsulinismdiagnosticandtherapeuticdifficulties